Genoray Co. Ltd (122310) - Total Liabilities
Based on the latest financial reports, Genoray Co. Ltd (122310) has total liabilities worth ₩47.48 Billion KRW (≈ $32.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 122310 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Genoray Co. Ltd - Total Liabilities Trend (2015–2025)
This chart illustrates how Genoray Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Genoray Co. Ltd (122310) total assets.
Genoray Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Genoray Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xiabuxiabu Catering Management (China) Holdings Co. Ltd
F:0XI
|
Germany | €2.32 Billion |
|
Texchem Resources Bhd
KLSE:8702
|
Malaysia | RM588.32 Million |
|
Bayu Buana Tbk
JK:BAYU
|
Indonesia | Rp402.19 Billion |
|
Porn Prom Metal Public Company Limited
BK:PPM
|
Thailand | ฿947.43 Million |
|
Ascent Solar Technologies, Inc.
NASDAQ:ASTI
|
USA | $2.83 Million |
|
SunCar Technology Group Inc.
NASDAQ:SDA
|
USA | $162.51 Million |
|
FORCS Co.Ltd
KQ:189690
|
Korea | ₩5.51 Billion |
|
Crown Crafts Inc
NASDAQ:CRWS
|
USA | $28.33 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Genoray Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Genoray Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genoray Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genoray Co. Ltd (2015–2025)
The table below shows the annual total liabilities of Genoray Co. Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩47.48 Billion ≈ $32.17 Million |
+26.43% |
| 2024-12-31 | ₩37.55 Billion ≈ $25.45 Million |
+30.68% |
| 2023-12-31 | ₩28.74 Billion ≈ $19.47 Million |
+57.59% |
| 2022-12-31 | ₩18.23 Billion ≈ $12.36 Million |
-11.29% |
| 2021-12-31 | ₩20.56 Billion ≈ $13.93 Million |
+6.96% |
| 2020-12-31 | ₩19.22 Billion ≈ $13.02 Million |
+1.51% |
| 2019-12-31 | ₩18.93 Billion ≈ $12.83 Million |
+40.58% |
| 2018-12-31 | ₩13.47 Billion ≈ $9.13 Million |
+0.24% |
| 2017-12-31 | ₩13.44 Billion ≈ $9.11 Million |
-27.72% |
| 2016-12-31 | ₩18.59 Billion ≈ $12.60 Million |
+8.17% |
| 2015-12-31 | ₩17.18 Billion ≈ $11.65 Million |
-- |
About Genoray Co. Ltd
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It provides C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded … Read more